An inverse association between history of childhood eczema and subsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ, PTPN22, or CTLA4 polymorphisms
Authors:
- 25 August 2010
- journal article
- research article
- Published by Hindawi Limited in Pediatric Diabetes
- Vol. 11 (6) , 386-393
Abstract
Established genetic susceptibility loci for type 1 diabetes are important in immune regulation and may play a role also in atopic disorders, potentially explaining the inverse association between childhood eczema and subsequent risk for type 1 diabetes previously reported. We aimed to directly assess whether HLA-DQ, CTLA4, and PTPN22 genes could explain the putative association between childhood eczema and lower subsequent risk of type 1 diabetes observed in several case-control studies. We designed a case-control study with 339 incident cases of type 1 diabetes identified in the Norwegian childhood diabetes registry, and 985 population-based control children. DNA was collected, and physician-diagnosed childhood eczema was ascertained by a questionnaire administered to the parents of children with and without type 1 diabetes. The previously reported association between childhood eczema and lower risk of type 1 diabetes was confirmed (odds ratio,OR, 0.61, 95% confidence interval, CI, 0.40-0.95] and this was consistent in subgroups defined by HLA-DQ, CTLA4, and PTPN22 genotypes. The OR was essentially not influenced by adjustment for genetic variation at these loci (OR simultaneously adjusted for the three genetic loci: 0.55, 95% CI: 0.32-0.92). The ratio of the unadjusted to adjusted OR was 1.12, with a corresponding 95% CI from 0.84 to 1.50. In this first study of its kind, we demonstrated directly that the observed inverse association between childhood eczema and type 1 diabetes is not likely to be explained by the established diabetes susceptibility genes HLA-DQ, CTLA4, or PTPN22.Keywords
This publication has 43 references indexed in Scilit:
- The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literatureClinical and Experimental Immunology, 2008
- Atopic DermatitisNew England Journal of Medicine, 2008
- Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetesNature Genetics, 2007
- Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveysThe Lancet, 2006
- Role of PTPN22 in type 1 diabetes and other autoimmune diseasesSeminars in Immunology, 2006
- Atopic disorders and risk of childhood‐onset type 1 diabetes in individualsClinical & Experimental Allergy, 2004
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- Type 1 diabetes: new perspectives on disease pathogenesis and treatmentThe Lancet, 2001
- Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control studyThe Lancet, 2001
- HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?Trends in Genetics, 2001